biology · ophthalmology and drug repurposing

Drug-repurposing directions for dry AMD

Identifying mechanistically plausible existing drugs that could improve retinal pigment epithelium function in dry age-related macular degeneration.

The tracked work produced an in-vitro direction, not a demonstrated treatment. Problem status therefore remains active research.

Open reference source ↗

Attempt ledger

What has been tried?

A complete attempt outcome does not automatically change the editorial status of the underlying problem.

May 2025 · caseRobin proposes a dry-AMD drug-repurposing direction

FutureHouse's Robin connected ROCK inhibition to improved retinal pigment epithelium phagocytosis and guided two experimental rounds; Y-27632 and ripasudil improved phagocytosis in vitro.

Partial progressExperimental evidence